Table of Contents
Chemotherapy Research and Practice
Volume 2012, Article ID 413589, 8 pages
http://dx.doi.org/10.1155/2012/413589
Clinical Study

Neoadjuvant Chemoradiation in Squamous Cell Carcinoma of the Maxillary Sinus: A 26-Year Experience

1Department of Oral and Cranio-Maxillo and Facial Plastic Surgery, University of Cologne, Kerpener Straße 62, 50931 Cologne, Germany
2Center of Integrated Oncology (CIO) Cologne-Bonn, Kerpener Straße 62, 50931 Cologne, Germany
3Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Kerpener Straße 62, 50931 Cologne, Germany
4Department of Radiotherapy and Radiation Oncology, University of Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany
5Department of Otorhinolaryngology, Head and Neck Surgery, Jena University Hospital, Kerpener Straße 62, 50931 Cologne, Germany

Received 15 May 2012; Revised 21 August 2012; Accepted 2 September 2012

Academic Editor: J. B. Vermorken

Copyright © 2012 Matthias Kreppel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Carrau, E. M. Myers, and J. T. Johnson, “Paranasal sinus carcinoma—diagnosis, treatment, and prognosis,” Oncology, vol. 6, no. 1, pp. 43–50, 1992. View at Google Scholar · View at Scopus
  2. C. S. Muir and J. Nectoux, “Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses,” Clinical Otolaryngology and Allied Sciences, vol. 5, no. 3, pp. 195–211, 1980. View at Google Scholar · View at Scopus
  3. P. Dulguerov and A. S. Allal, “Nasal and paranasal sinus carcinoma: how can we continue to make progress?” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 14, no. 2, pp. 67–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Dulguerov, M. S. Jacobsen, A. S. Allal et al., “Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review,” Cancer, vol. 92, no. 12, pp. 3012–3029, 2003. View at Google Scholar
  5. M. Kreppel, M. Scheer, D. Beutner et al., “Stage grouping un tumoes of the ethmoid sinuses and the nasal cavity using the sixth edition of the UICC classification of malignant tumors,” Head & Neck, vol. 33, pp. 1467–1475, 2011. View at Google Scholar
  6. F. L. Greene and L. H. Sobin, “The staging of cancer: a retrospective and prospective appraisal,” CA: A Cancer Journal for Clinicians, vol. 58, no. 3, pp. 180–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Guntinas-Lichius, M. P. Kreppel, H. Stuetzer, R. Semrau, H. E. Eckel, and R. P. Mueller, “Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients,” European Journal of Surgical Oncology, vol. 33, no. 2, pp. 222–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Goldenberg, A. Golz, M. Fradis, D. Mârtu, A. Netzer, and H. Z. Joachims, “Malignant tumors of the nose and paranasal sinuses: a retrospective review of 291 cases,” Ear, Nose and Throat Journal, vol. 80, no. 4, pp. 272–277, 2001. View at Google Scholar · View at Scopus
  9. W. R. Panje, A. J. Namon, E. Vokes, D. J. Haraf, and R. R. Weichselbaum, “How I do it: head and neck and plastic surgery: surgical management of the head and neck cancer patient following concomitant multimodality therapy,” The Laryngoscope, vol. 105, no. 1, pp. 97–101, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Bhattacharyya, “Survival and staging characteristics for non-squamous cell malignancies of the maxillary sinus,” Archives of Otolaryngology—Head & Neck Surgery, vol. 129, no. 3, pp. 334–337, 2003. View at Google Scholar · View at Scopus
  11. C. Grau, M. H. Jakobsen, G. Harbo et al., “Sino-nasal cancer in Denmark 1982–1991: a nationwide survey,” Acta Oncologica, vol. 40, no. 1, pp. 19–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. T. S. Katz, W. M. Mendenhall, C. G. Morris, R. J. Amdur, R. W. Hinerman, and D. B. Villaret, “Malignant tumors of the nasal cavity and paranasal sinuses,” Head and Neck, vol. 24, no. 9, pp. 821–829, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Bernier, C. Domenge, M. Ozsahin et al., “Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer,” The New England Journal of Medicine, vol. 350, no. 19, pp. 1945–1952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Cooper, T. F. Pajak, A. A. Forastiere et al., “Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck,” New England Journal of Medicine, vol. 350, no. 19, pp. 1937–2019, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Adelstein, Y. Li, G. L. Adams et al., “An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer,” Journal of Clinical Oncology, vol. 21, no. 1, pp. 92–98, 2003. View at Google Scholar · View at Scopus
  16. J. M. Bachaud, E. Cohen-Jonathan, C. Alzieu, J. M. David, E. Serrano, and N. Daly-Schveitzer, “Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial,” International Journal of Radiation Oncology Biology Physics, vol. 36, no. 5, pp. 999–1004, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Bernier, “Current state-of-the-art for concurrent chemoradiation,” Seminars in Radiation Oncology, vol. 19, no. 1, pp. 3–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Pignon, J. Bourhis, C. Domenge, L. Designé, and MACH-NC Collaborative Group, “Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data,” The Lancet, vol. 355, no. 9208, pp. 949–955, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Amptoulach and N. Tsavaris, “Neurotoxicity caused by the treatment with platinum analogues,” Chemotherapy Research and Practice, vol. 2011, Article ID 843019, 5 pages, 2011. View at Publisher · View at Google Scholar
  20. H. T. Eich, M. Löschcke, M. Scheer et al., “Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity: outcome of 134 patients,” Strahlentherapie und Onkologie, vol. 184, no. 1, pp. 23–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Freier, M. Engel, K. Lindel et al., “Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients,” Oral Oncology, vol. 44, no. 2, pp. 116–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kirita, K. Ohgi, H. Shimooka et al., “Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results,” Oral Oncology, vol. 35, no. 6, pp. 597–606, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Klug, D. Berzaczy, M. Voracek et al., “Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients,” Journal of Cranio-Maxillofacial Surgery, vol. 37, no. 6, pp. 344–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. J. Slotman, C. H. Doolittle, and A. S. Glicksman, “Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival,” Cancer, vol. 69, no. 11, pp. 2736–2743, 1992. View at Google Scholar
  25. M. Kreppel, H. T. Eich, C. Brüggenolte et al., “Preoperative vs. postoperative radiochemotherapy in patients with N2 squamous cell carcinoma of the oral cavity,” Oral Oncology. In press. View at Publisher · View at Google Scholar
  26. J. Wennerberg, “Pre versus post-operative radiotherapy of resectable squamous cell carcinoma of the head and neck,” Acta Oto-Laryngologica, vol. 115, no. 4, pp. 465–474, 1995. View at Google Scholar · View at Scopus
  27. G. Calais, M. Alfonsi, E. Bardet et al., “Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma,” Journal of the National Cancer Institute, vol. 91, no. 24, pp. 2081–2086, 1999. View at Google Scholar · View at Scopus
  28. D. Knöbber, H. Sack, H. Stützer, and K. G. Rose, “Pre-irradiation and surgery of patients with squamous cell carcinoma of the oral cavity and oropharynx: the results of a 1973–1984 study,” Strahlentherapie und Onkologie, vol. 163, no. 11, pp. 706–713, 1987. View at Google Scholar · View at Scopus
  29. R. P. Müller, S. Staar, M. Samek, and H. D. Pape, “Simultaneous preoperative radiochemotherapy with cisplatin in advanced oral cavity carcinomas: acute response and follow-up,” Recent Results in Cancer Research, vol. 134, pp. 165–172, 1994. View at Google Scholar · View at Scopus
  30. C. Wittekindt and H. J. Meyer, “Head neck cancer,” in UICC's TNM-Classification of Malignant Tumors, pp. 23–60, Springer, Berlin, Germany, 2010. View at Google Scholar
  31. E. L. Kaplan and P. Meier, “Non-parametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, no. 282, pp. 457–481, 1958. View at Publisher · View at Google Scholar
  32. D. Cox, “Regression modell and life-tables,” Journal of the Royal Statistical Society B, no. 2, pp. 187–220, 1972. View at Google Scholar
  33. D. Brasnu, O. Laccourreye, V. Bassot, L. Laccourreye, P. Naudo, and F. X. Roux, “Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base,” Archives of Otolaryngology—Head & Neck Surgery, vol. 122, no. 7, pp. 765–768, 1996. View at Google Scholar · View at Scopus
  34. J. Kang, S. Cho, J. Pyeong-Kim et al., “Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis,” Journal of Oral and Maxillofacial Surgery, vol. 70, no. 7, pp. 1717–1723, 2012. View at Publisher · View at Google Scholar
  35. W. Mann and C. Schuler-Voith, “Tumors of the paranasal sinuses and the nose—a retrospective study in 136 patients,” Rhinology, vol. 21, no. 2, pp. 173–177, 1983. View at Google Scholar · View at Scopus
  36. K. I. Nibu, M. Sugasawa, M. Asai et al., “Results of multimodality therapy for squamous cell carcinoma of maxillary sinus,” Cancer, vol. 94, no. 5, pp. 1476–1482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Sakai, A. Hohki, H. Fuchihata, and Y. Tanaka, “Multidisciplinary treatment of maxillary sinus carcinoma,” Cancer, vol. 52, no. 8, pp. 1360–1364, 1983. View at Google Scholar · View at Scopus
  38. G. Harbo, T. Bundgaard, J. Overgaard et al., “Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients,” Acta Oncologica, vol. 36, no. 1, pp. 45–50, 1997. View at Google Scholar · View at Scopus
  39. G. L. Jiang, S. L. Tucker, R. Guttenberger et al., “Radiation-induced injury to the visual pathway,” Radiotherapy and Oncology, vol. 30, no. 1, pp. 17–25, 1994. View at Publisher · View at Google Scholar
  40. J. T. Parsons, F. C. Kimsey, W. M. Mendenhall, R. R. Million, N. J. Cassisi, and S. P. Stringer, “Radiation therapy for sinus malignancies,” Otolaryngologic Clinics of North America, vol. 28, no. 6, pp. 1259–1268, 1995. View at Google Scholar · View at Scopus
  41. K. Isobe, T. Uno, T. Hanazawa et al., “Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus,” Japanese Journal of Clinical Oncology, vol. 35, no. 11, pp. 633–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ashraf, J. Biswas, A. Dam et al., “Results of treatment of squamous cell carcinoma of the maxillary sinus a 26-year experience,” World Journal of Oncology, vol. 1, no. 1, pp. 28–34, 2010. View at Google Scholar
  43. A. S. Glicksman, G. J. Slotman, C. H. Doolittle et al., “Concurrent CIS-platinum and radiation with or without surgery for advanced head and neck cancer,” International Journal of Radiation Oncology Biology Physics, vol. 30, no. 5, pp. 1043–1050, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. R. H. Jesse, “Preoperative versus postoperative radiation in the treatment of squamous carcinoma of the paranasal sinuses,” The American Journal of Surgery, vol. 110, no. 4, pp. 552–556, 1965. View at Google Scholar · View at Scopus
  45. Y. Hu, G. Tu, Y. Qi et al., “Comparison of pre- and postoperative radiation in the combined treatment of carcinoma of maxillary sinus,” International Journal of Radiation Oncology Biology Physics, vol. 8, no. 6, pp. 1045–1049, 1982. View at Google Scholar · View at Scopus
  46. J. P. Pignon, A. L. Maître, E. Maillard, and J. Bourhis, “Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients,” Radiotherapy & Oncology, vol. 92, no. 1, pp. 4–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. M. L. Madison, J. M. Sorenson, S. Samant, and J. H. Robertson, “The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation,” Journal of Neuro-Oncology, vol. 72, no. 1, pp. 67–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. L. L. Myers, B. Nussenbaum, C. R. Bradford, T. N. Teknos, R. M. Esclamado, and G. T. Wolf, “Paranasal sinus malignancies: an 18-year single institution experience,” Laryngoscope, vol. 112, no. 11, pp. 1964–1969, 2002. View at Google Scholar · View at Scopus
  49. G. E. Kim, E. J. Chung, J. J. Lim et al., “Clinical significance of neck node metastasis in squamous cell carcinoma of the maxillary antrum,” American Journal of Otolaryngology, vol. 20, no. 6, pp. 383–390, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Y. Hanna, A. D. Cardenas, F. DeMonte et al., “Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses,” Archives of Otolaryngology—Head & Neck Surgery, vol. 137, no. 1, pp. 78–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. V. A. Papadimitrakopoulou, L. E. Ginsberg, A. S. Garden et al., “Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma,” Cancer, vol. 98, no. 10, pp. 2214–2223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Lee, E. Vokes, A. Rosen, M. E. Witt, R. R. Weichselbaum, and D. J. Haraf, “Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results,” The Cancer Journal from Scientific American, vol. 5, no. 4, pp. 219–223, 1999. View at Google Scholar · View at Scopus
  53. S. Samant, K. T. Robbins, M. Vang, J. Wan, and J. Robertson, “Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer,” Archives of Otolaryngology—Head & Neck Surgery, vol. 130, no. 8, pp. 948–955, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Driemel, T. Ettl, O. Kölbl et al., “Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy,” Strahlentherapie und Onkologie, vol. 185, no. 5, pp. 296–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. W. M. Koch, J. A. Ridge, A. Forastiere, and J. Manola, “Comparison of clinical and pathological staging in head and neck squamous cell carcinoma—results from Intergroup Study ECOG 4393/RTOG 9614,” Archives of Otolaryngology—Head & Neck Surgery, vol. 135, no. 9, pp. 851–858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Fan, C. Lin, C. Kang et al., “Combined-modality treatment for advanced oral tongue squamous cell carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 2, pp. 453–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Soo, E. Tan, J. Wee et al., “Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison,” British Journal of Cancer, vol. 93, no. 3, pp. 279–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Mohr, W. Bohndorf, J. Carstens et al., “Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up),” International Journal of Oral and Maxillofacial Surgery, vol. 23, no. 3, pp. 140–148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. L. De Andrés, J. Brunet, A. López-Pousa et al., “Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer,” Journal of Clinical Oncology, vol. 13, no. 6, pp. 1493–1500, 1995. View at Google Scholar · View at Scopus
  60. A. A. Forastiere, B. Metch, D. E. Schuller et al., “Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study,” Journal of Clinical Oncology, vol. 10, no. 8, pp. 1245–1251, 1992. View at Google Scholar · View at Scopus